BackVirpax Pharmaceuticals Overview

Virpax Pharmaceuticals Operating Income

Operating Income for VRPX.

Quarterly Operating Income

$-3394742.00
↓ 27.53% YoY

As of Dec 31, 2024

Annual Operating Income (TTM)

$-12079936.00
↓ 23.01% YoY

Trailing 12 months ending Dec 31, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin